Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Kite adds promising leukemia responses in small CAR-T studies, then fires the starting gun on its rolling submission
Kite adds promising leukemia responses in small CAR-T studies, then fires the starting gun on its rolling submission
Kite adds promising leukemia responses in small CAR-T studies, then fires the starting gun on its rolling submission
Submitted by
admin
on December 5, 2016 - 10:01am
Source:
Endpoints
News Tags:
Kite Pharma
CAR-T
clinical trials
KTE-C19
acute lymphoblastic leukemia
Headline:
Kite adds promising leukemia responses in small CAR-T studies, then fires the starting gun on its rolling submission
Do Not Allow Advertisers to Use My Personal information
